Atlas FDA

COLOGUARD

FDA premarket approval P130017/S035 · decided 2019-10-24

Approval details

PMA number
P130017
Supplement
S035
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
COLOGUARD
Generic name
System, colorectal neoplasia, DNA methylation and hemoglobin detection
Applicant
Exact Sciences Corporation
Date received
2019-09-27
Decision date
2019-10-24
Days to decision
27 days
Decision code
OK30
Product code
PHP
Advisory committee
Pathology
Expedited review
No
Location
Medison, WI
Statement
Reagent manufacturing scale-up.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.